Form 4 holding
Chief Scientific Officer
Keros Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 95,100
- Estimated value
- $4,307,079
- Report date
- 15 Jul 2022
- Price
- $45.29
- Ownership
- Direct
Jennifer Lachey - Chief Scientific Officer at Keros Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Scientific Officer
- Issuer ticker
- KROS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jennifer Lachey since 05 Sep 2025
Reported holdings for Jennifer Lachey in Keros Therapeutics, Inc.
Form 4 holding
Chief Scientific Officer
Keros Therapeutics, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 8,755
- Estimated value
- Report date
- 15 Jul 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jennifer Lachey in Keros Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.